| scholarly article | Q13442814 |
| P2093 | author name string | Fish JC | |
| Vaidya S | |||
| Gitomer J | |||
| Kimball P | |||
| Sellers R | |||
| Shanahan T | |||
| Gugliuzza K | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney disease | Q1054718 |
| antibody | Q79460 | ||
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 1348-1352 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study | |
| P478 | volume | 69 |
| Q38885685 | Anti-phospholipid Antibodies and Smoking: An Overview |
| Q46466244 | Antiphospholipid antibodies in renal allograft recipients. |
| Q34354745 | Antiphospholipid antibodies. Risk assessments for solid organ, bone marrow, and tissue transplantation |
| Q37371383 | Beyond immunosuppression - challenges in the clinical management of lupus nephritis |
| Q34261036 | Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation |
| Q82137974 | Clinical significance of antiphospholipid antibodies on allograft and patient outcome after kidney transplantation |
| Q35947003 | Coagulopathies and the kidney |
| Q24645234 | Disease recurrence in paediatric renal transplantation |
| Q74456594 | Hughes (antiphospholipid) syndrome. Clinical features |
| Q36302245 | Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis |
| Q46452620 | Management of end-stage renal disease patients with antiphospholipid antibody syndrome |
| Q28196178 | Management of the antiphospholipid syndrome |
| Q28194004 | Management of thrombophilia in renal transplant patients |
| Q38920147 | Outcomes in Renal Transplant Recipients With Lupus Nephritis-A Single-Center Experience and Review of the Literature. |
| Q38211785 | Perioperative management of antiphospholipid antibody-positive patients |
| Q58004323 | Plasma exchange in a patient with primary antiphospholipid syndrome undergoing kidney transplantation |
| Q37476122 | Prevalence of anti- beta2GPI antibodies and their isotypes in patients with renal diseases and clinical suspicion of antiphospholipid syndrome |
| Q34354761 | Prognosis in antiphospholipid syndrome |
| Q74417479 | Renal allograft loss due to proximal extension of ileofemoral deep venous thrombosis |
| Q34397891 | Renal transplantation in lupus nephritis |
| Q77068531 | Renal vein thrombosis after renal transplantation: an important cause of graft loss |
| Q38374309 | Reviewing the recommendations for lupus in children |
| Q74774458 | Role of anti-beta 2 glycoprotein 1 antibodies in ESRD patients with antiphospholipid antibody syndrome |
| Q45100303 | Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation |
| Q34354700 | Which antiphospholipid antibody tests are most useful? |
| Q78679215 | [Current therapy of lupus nephritis] |
| Q78506325 | [Kidney, lupus and pregnancy] |
Search more.